News
Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...
NEWCASTLE, UK I April 25, 2025 I Iksuda Therapeutics (Iksuda), the developer of class leading, clinically validated antibody drug conjugates (ADCs) today announces that it will present three posters ...
Anti-IL1RAP ADC demonstrated potent anti-tumor efficacy and was well tolerated in pre-clinical models Anti-IL1RAP ADC targets ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years.
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation ...
NK cells complexed with bispecific antibody yield high response rates in patients with lymphoma. ScienceDaily . Retrieved April 29, 2025 from www.sciencedaily.com / releases / 2025 / 04 ...
Get Instant Summarized Text (Gist) A clinical trial demonstrated that cord blood-derived natural killer (NK) cells pre-complexed with the bispecific antibody AFM13 showed high efficacy in treating ...
State Key Laboratory of Vaccines for Infectious Diseases, Center for Molecular Imaging and Translational Medicine, Xiang’An Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen ...
Division of Physical Biology, CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China University of Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results